Followers | 15 |
Posts | 151 |
Boards Moderated | 0 |
Alias Born | 06/20/2020 |
Tuesday, January 19, 2021 5:46:15 PM
As I write this, buyers are coming in during aftermarket trading, note AIKI traded between $1.03 and $1.12 today, and closed at $1.10.
As I write this, I'm watching AIKI trade right now in after-market hours between $1.30 and $1.35/share.
Wednesday could be potentially a gigantic day for AIKI investors.
If you haven't taken a look at this stock yet, this is your chance. AIKI is witnessing a major momentum run.
The Company has several bullish catalysts on the horizon, and is on the verge of disrupting a $176BIL Anti-Cancer Therapeutics Market, and Recent Blockbuster News AIKI Executes Licensing Agreement for Psilocybin for Cancer Applications.
Sincerely,
Editor In Chief, OTCtipReporter Team
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM